Navigation Links
CareMetx, LLC Combines Operations with Walgreens-Owned Pharma Dynamics, Inc.
Date:11/20/2013

Bethesda, MD (PRWEB) November 20, 2013

CareMetx, LLC and Pharma Dynamics, Inc. (PDI) have entered into an agreement to combine operations effective November 19, 2013 under the CareMetx name. CareMetx is a privately held technology and specialty hub services company serving drug and device manufacturers. PDI is a Walgreens-owned entity providing new product launch support and call center services for drug manufacturers. The agreement provides the combined company with enhanced growth opportunities and improved service offerings for its customers. The combined company will be majority owned by CareMetx’ current owners.

“This is a combination of two like-minded entities whose primary focus is on serving the patient,” said Robert K. Dresing, Chairman of CareMetx. “PDI’s call center expertise coupled with CareMetx technology and services will bring new innovative options to manufacturers.”

CareMetx, LLC was founded in 2011 by Dresing and Mark Hansan, entrepreneurs and longtime partners with extensive experience in the specialty drug commercialization business. As founders of TheraCom, a specialty pharmacy and services company, they established a business model that supported drug manufacturers in getting their innovative products to market using state-of-the-art technology and high-touch human services, a combination that became the standard for the industry.

“CareMetx has built technology that will set new standards in the life sciences industry, assuring more responsive care programs and improved intelligence for our clients old and new,” Mark Hansan, President and CEO of CareMetx, stated. “The ability to provide patients with a higher-level of service through better data is what motivates our team to create innovative digital solutions. We are excited to be expanding our offering with the help of the PDI team.”

“The combination of CareMetx and PDI will create a dynamic hub services provider that can deliver innovative solutions for drug manufacturers, with a sharp focus on delivering high quality health care services to patients,” said Mike Ellis, Walgreens Corporate Vice President, Specialty Pharmacy and Infusion. “We’re confident this joining of complementary expertise will allow CareMetx to become the technology and service leader in the specialty industry for many years to come.”

About Pharma Dynamics Inc.
Pharma Dynamics, Inc. (PDI) is a Walgreens-owned entity. Pharma Dynamics serves drug manufacturers in the launch of their new products with reimbursement and call centers.

About CareMetx
CareMetx, LLC is a privately held, Bethesda, MD-based company serving pharmaceutical, biotech and device manufacturers with proprietary technology and specialty hub services to commercialize their complex, innovative products.

Read the full story at http://www.prweb.com/releases/caremetx/merger/prweb11351059.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Shimadzu's New MALDI-7090 TOF-TOF Mass Spectrometer Combines High Throughput, High Resolution and High Energy for the Ultimate in Tandem MS Capabilities
2. Fantastic flash memory combines graphene and molybdenite
3. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
4. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
5. ISPE Names Dr. Thomas Zimmer as Vice President of European Operations
6. TrialNetworks Sees Strong Growth in Demand for its Clinical Trial Optimization System as Pharma Seeks Technology to Improve Operations Quality and Efficiency
7. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
8. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
9. SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
10. Emerging Global Leader in Emergency Thermotherapy for Traumatic Brain Injury Expands US Operations to Site on the Campus of New York Medical College
11. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... FireflySci Inc. is a go-getter type of company that continues to grow ... main factors. The first is the amazing customer service that the FireflySci staff ... around the world. , 2016 was a tremendous sales year for FFS and much ...
(Date:1/19/2017)... 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), ... for operable and inoperable solid tumor cancers, announced today ... of NW Bio, will present at the Phacilitate Immunotherapy ... Hyatt Regency Hotel in Miami, Florida ... entitled "New Therapeutic Approaches – Expanding the Reach of ...
(Date:1/18/2017)... OR (PRWEB) , ... January 18, 2017 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 ... Cyclone V E FPGA into a compact business-card sized form factor suitable for ...
(Date:1/18/2017)... Jan. 18, 2017 Applied BioMath ( ... to drug research and development, today announced that ... and CEO of Applied BioMath, will present at ... Modeling (BAGIM) Meeting on Thursday January 19, 2017 ... , MA.   Dr. Burke,s talk "Quantitative Modeling ...
Breaking Biology Technology:
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/12/2017)... SAN DIEGO , Jan. 12, 2017  Trovagene, ... circulating tumor DNA (ctDNA) technologies, today announced that it ... Europe and the Middle ... biopsy tests.  This milestone marks the first wave of ... tests for urine and blood samples. The ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
Breaking Biology News(10 mins):